DAVID BATTISTE: Open Payments
NPI 1508416496 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 22 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $84 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $84 |
| PFIZER INC. | 3 | $64 |
| Novo Nordisk Inc | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Astellas Pharma US Inc | 1 | $25 |
| Seqirus USA Inc | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: REXULTI, QULIPTA, PAXLOVID, VRAYLAR, SHINGRIX, NURTEC ODT, Veozah, Fluad.
Industry payments across CO — which companies pay providers there.
